Physician

Nancy Rose Frappier, MD

According to 2025 Medicare claims, Nancy Frappier, MD (NPI: 1598762510) practices neurology in the Kokomo, IN market, with the plurality of this provider's patient population coming from Howard, IN. This provider's primary affiliated billing organization is ST. VINCENT MEDICAL GROUP, INC. (NPI: 1144513375; TIN: 272039417) and primary practice location at 46902-6069. Frappier is affiliated with the Ascension Care Management (ACO ID: A2600) and CHSPSC ACO 2, LLC (ACO ID: A3664), participating under the MSSP model.

Frappier's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 672 traditional Medicare patients, billed 1,056 HCPCS/CPT codes, and received $93,164 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 8,239 prescription claims across 993 beneficiaries totaling $1,997,372 in drug costs, led by Kesimpta Pen (Ofatumumab). 2022 DME data shows 30 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $148,983 to $93,164. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $44,007 to $3,420.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$74K$149K2015 Medicare payment: $148,983 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $132,779 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $136,391 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $134,872 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $128,151 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $100,148 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $106,474 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $99,316 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $90,095 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $93,164 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159732,039$148,983
20169051,821$132,779
20179581,941$136,391
20188981,761$134,872
20198381,610$128,151
20208091,409$100,148
20217161,315$106,474
20226501,112$99,316
20236581,081$90,095
20246721,056$93,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.7M2015 Drug cost: $2,781,314 (USD; Tot_Drug_Cst)2016 Drug cost: $3,208,955 (USD; Tot_Drug_Cst)2017 Drug cost: $2,950,910 (USD; Tot_Drug_Cst)2018 Drug cost: $3,172,130 (USD; Tot_Drug_Cst)2019 Drug cost: $3,401,057 (USD; Tot_Drug_Cst)2020 Drug cost: $3,733,469 (USD; Tot_Drug_Cst)2021 Drug cost: $3,701,491 (USD; Tot_Drug_Cst)2022 Drug cost: $3,377,014 (USD; Tot_Drug_Cst)2023 Drug cost: $2,469,938 (USD; Tot_Drug_Cst)2024 Drug cost: $1,997,372 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157627,566$2,781,314
20167467,348$3,208,955
20177396,664$2,950,910
20187626,828$3,172,130
20197996,451$3,401,057
20208077,197$3,733,469
20218397,763$3,701,491
20228607,892$3,377,014
20239008,059$2,469,938
20249938,239$1,997,372

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.0K$6.0K2015 Medicare payment: $4,042 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,979 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,006 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $753 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,389 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $822 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,005 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $823 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R36$4,042
2016N/R81$5,979
2017N/R75$3,006
2018N/R38$753
2019N/R12$1,389
2020N/R25$822
2021N/R35$2,005
2022N/R30$823
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more114114$148
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more93105$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more350412$80
95886Needle measurement of electrical activity in arm or leg muscles, complete study4872$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more109115$57

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Kesimpta PenOfatumumab31910$334,029
TeriflunomideTeriflunomide782,340$174,722
AubagioTeriflunomide12360$111,761
Plegridy PenPeginterferon Beta-1a12336$93,151
QuliptaAtogepant732,370$89,928

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$25Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nancy Rose Frappier, MD?

Tedicare shows public-source Medicare data for Nancy Rose Frappier, MD (NPI 1598762510), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nancy Rose Frappier, MD have ACO affiliation data?

Nancy Rose Frappier, MD is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A2600) and CHSPSC ACO 2, LLC (MSSP, ACO ID A3664).

What billing organization is linked to Nancy Rose Frappier, MD?

Nancy Rose Frappier, MD is linked to ST. VINCENT MEDICAL GROUP, INC. (billing NPI 1144513375) in the available physician profile data.

Does Nancy Rose Frappier, MD have Open Payments data?

Nancy Rose Frappier, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.